Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
about
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerRecent developments and translational aspects in targeted therapy for metastatic breast cancerPathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situTriple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.Novel therapeutic strategies in the treatment of triple-negative breast cancer.cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancerMET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.
P2860
Q28067777-30F8FBAD-580D-461B-BA4C-D972CF1C25C3Q28072755-37C931E6-DD75-42BD-BADF-8280BD0802F1Q29994686-3384DD45-759E-4728-82CE-024C5C71AE1DQ33769821-885CCED1-0C98-4105-808F-F96E7204C2A0Q33880049-7FDE01F6-BFF8-4D8D-A2DB-799D85AB2653Q33887682-61BEA322-5E70-467D-B7C6-B166EDE50C03Q36703854-4F625261-13AF-4ED8-9674-F006B889B84EQ37597858-A7A6B9C2-260F-4082-8905-1EC6D22F3A96Q37629000-B1CEA45F-C063-4768-858E-C0DB2F36AFA3Q38693843-66E744B1-A17B-4282-802F-2DF0D5A9AEE4Q38803271-9493A308-E5B5-4FD2-B79C-CFB8FB95D985Q38979283-DFF738CC-17F8-4080-922B-072815E196FFQ52550597-F2E57AB4-A0A5-4E30-99BA-19BFA5C8DBB3
P2860
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@ast
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@en
type
label
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@ast
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@en
prefLabel
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@ast
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@en
P2093
P2860
P1476
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
@en
P2093
Andrew Borgman
Anita Chalasani
Arulselvi Anbalagan
Bonnie F Sloane
Carrie R Graveel
Curt J Essenburg
David M Cherba
Elizabeth A Tovar
Erik S Linklater
Mansoureh Sameni
P2860
P304
P356
10.1158/1078-0432.CCR-15-0187
P407
P577
2015-10-02T00:00:00Z